Key Takeaways & Executive Findings
- •• Single-cell RNA sequencing identifies five distinct megakaryocyte (MK) subsets (MK1–MK5) in peripheral blood, with MK1 and MK2 predominant in PICS patients. • MK1 shows enrichment in antigen processing/presentation and IL-17 signaling, while MK2 is associated with platelet degranulation and neutrophil activation, indicating functional specialization. • CCL5 expression is markedly upregulated in MKs, and ligand-receptor analysis reveals dynamic interactions with various immune cells, suggesting a broad immunoregulatory role. • In a PICS mouse model, MKs reduce systemic inflammation by lowering TNF-α and IL-17A levels and promote lung tissue repair, highlighting their potential as therapeutic targets for post-sepsis immune dysfunction.
Abstract
Persistent inflammation-immunosuppression and catabolism syndrome (PICS) is a severe condition that may follow sepsis and is characterized by ongoing inflammation and immune suppression, diminishing quality of life and potentially causing death. The role of megakaryocytes (MKs) in PICS, despite their association with thrombopoiesis, is not well understood. In this study, we use single-cell RNA sequencing to profile MKs in peripheral blood mononuclear cell samples obtained from 11 patients, including six with PICS, five with sepsis, and five healthy controls, to determine the diversity and molecular signatures of the MKs. Five subgroups of MKs are identified (MK1–MK5), and their proportions vary across the groups. MK1 and MK2 are predominant in PICS. Gene Ontology analysis shows that genes related to antigen processing and presentation and IL-17 signaling are enriched in MK1, whereas genes associated with platelet degranulation and neutrophil activation are enriched in MK2. Moreover, the expression level of CCL5 is markedly increased in MKs. Ligand-receptor analysis reveals dynamic interactions among MKs and T cells, B cells, natural killer cells, monocytes, and macrophages, suggesting a broad role of MKs in immune homeostasis. In PICS model mice, MKs regulate systemic inflammation by reducing the levels of the proinflammatory cytokines TNF-α and IL-17A and promoting lung tissue repair. Our findings establish MKs as essential components of the immune system in PICS and provide new insights into their potential as therapeutic targets for post-sepsis immune dysfunction.
1. Introduction
Sepsis, a major cause of morbidity and mortality worldwide, can lead to multiple organ dysfunction and long-term immune alterations [1]. Individuals who survive sepsis may experience “persistent inflammation-immunosuppression, and catabolism syndrome” (PICS), a condition characterized by metabolic derangements, immune dysfunction, and increased susceptibility to secondary infections [2–4].
Although the precise mechanisms underlying PICS remain to be elucidated, elevated levels of C-reactive protein (CRP), myeloid-derived suppressor cells, and inflammatory cytokines, including interleukin (IL)-6 and IL-8, are associated with the pathogenesis of PICS [5]. Many previous studies have focused on the role of myeloid cells and lymphocytes in sepsis-induced immune suppression [1,6]. However, recent evidence suggests that megakaryocytes (MKs), which are traditionally considered to function as platelet progenitors [7–9], may contribute to immune regulation and inflammation in the PICS. MKs have been implicated in several inflammatory diseases, with roles in regulating neutrophil activation, modulating adaptive immunity, and contributing to the resolution of inflammation [10–12]. However, the heterogeneity and functional dynamics of MKs in pathological states are underexplored, and the precise role of MKs in PICS remains unclear.
Single-cell RNA sequencing (scRNA-seq) has revolutionized the characterization of cellular diversity, enabling the identification of novel immune cell subsets and their molecular signatures. In the present study, we systematically characterized the MKs of patients with PICS, septic patients, and healthy individuals using single-cell transcriptomics. The role of MKs in the immune response during PICS secondary to sepsis was also assessed. Our findings revealed extensive MK reprogramming in the PICS and suggested that MKs play an immunoregulatory role in the PICS, potentially influencing post-sepsis immune homeostasis. Our results provide a comprehensive overview of the role of MKs in the immune landscape of patients with PICS following sepsis.
Loading authentic research manuscript (Pages 1–5)...
Xingfeng Sun, Ke Nan, Ziwen Zhong, Zhiqiang Liu, Changhong Miao (2026). Immune signatures of megakaryocytes in persistent inflammation-immunosuppression and catabolism syndrome. Acta Biochimica et Biophysica Sinica. https://doi.org/10.3724/abbs.2025087
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is persistent inflammation-immunosuppression and catabolism syndrome (PICS)?
PICS is a severe condition that may follow sepsis, characterized by ongoing inflammation, immune suppression, and metabolic derangements, leading to diminished quality of life and potentially death.
How were megakaryocytes (MKs) studied in this research?
The researchers used single-cell RNA sequencing to profile MKs from peripheral blood mononuclear cells of patients with PICS, sepsis, and healthy controls, identifying five distinct MK subsets and analyzing their molecular signatures and interactions.
What are the main findings regarding MK subsets in PICS?
MK1 and MK2 are predominant in PICS. MK1 shows enrichment in antigen processing and IL-17 signaling, while MK2 is associated with platelet degranulation and neutrophil activation, indicating functional specialization.
What is the clinical significance of this study?
The study establishes MKs as essential components of the immune system in PICS and suggests they could be therapeutic targets for post-sepsis immune dysfunction, potentially improving patient outcomes.
How do MKs affect inflammation in a PICS mouse model?
In PICS model mice, MKs regulate systemic inflammation by reducing levels of proinflammatory cytokines TNF-α and IL-17A and promoting lung tissue repair.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.